VRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced on the potential of future earnings. The short and long-moving averages ratio shows bullish momentum also shows strength with an upper Bollinger Band "walk". Price has climbed...
One more COVID idea, could just grab some commons and wait to see if there is any merit to their Antiviral nasal spray. In on some commons at $4.40, will wait a few weeks to see if this catches any strength
VRPX is another one of the former penny stock darlings of the year. Big breakout mid August put it on everyone's radars now it's about sustaining this higher price level and subsequent valuation. At today's price of around $20.25, the market cap is 3.5x the size it was just a few weeks ago. Thanks to FDA related headlines, VRPX stock skyrocketed. "The FDA has...
There was a clear rejection at pre-market high, so the opening range breakout at 9.35 was only good for a 2$ move. In such case I like to short a stock till prior days closing price.
Pharma stocks trade pretty similar, there is a bull run to a certain level then a sharp correction. Today VRPX was a valid long trade up to the ATH level at 8.50 and then to the 10$ mark. As usual the pre-market scanner alerted me to go long on a new high of the most bullish stock...
ongoing short/long war I'm personally vested in... booooooy that squeeze could be LOVELY